Douglas C. Watson

1.1k total citations
32 papers, 853 citations indexed

About

Douglas C. Watson is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Douglas C. Watson has authored 32 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Virology and 6 papers in Immunology. Recurrent topics in Douglas C. Watson's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (6 papers). Douglas C. Watson is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (6 papers). Douglas C. Watson collaborates with scholars based in United States, Zambia and Canada. Douglas C. Watson's co-authors include John Farley, John B. Robbins, Shousun C. Szu, Rachel Schneerson, Joseph Shiloach, Ali Fattom, D Bryla, Deborah Persaud, George K. Siberry and Aima A. Ahonkhai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and The Journal of Immunology.

In The Last Decade

Douglas C. Watson

31 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas C. Watson United States 14 516 289 149 143 134 32 853
Bor-Shen Hu Taiwan 15 705 1.4× 162 0.6× 241 1.6× 240 1.7× 76 0.6× 30 1.2k
Nguyen Vu Trung Vietnam 20 384 0.7× 63 0.2× 100 0.7× 282 2.0× 76 0.6× 44 989
Jenna Rychert United States 19 433 0.8× 389 1.3× 132 0.9× 484 3.4× 359 2.7× 31 1.4k
Stuart McCorrister Canada 18 214 0.4× 114 0.4× 87 0.6× 271 1.9× 184 1.4× 35 969
Marcelo Mendonça Brazil 17 382 0.7× 59 0.2× 76 0.5× 89 0.6× 129 1.0× 40 909
Christopher Birch Australia 17 607 1.2× 307 1.1× 71 0.5× 390 2.7× 114 0.9× 30 1.2k
Rebecca C. Brady United States 21 528 1.0× 100 0.3× 111 0.7× 1.1k 7.6× 393 2.9× 55 1.6k
Lisa A. Cosimi United States 11 203 0.4× 182 0.6× 71 0.5× 199 1.4× 175 1.3× 22 720
William Kabat United States 14 418 0.8× 107 0.4× 46 0.3× 230 1.6× 74 0.6× 27 693
Linda C. Green United States 14 205 0.4× 227 0.8× 36 0.2× 143 1.0× 101 0.8× 20 661

Countries citing papers authored by Douglas C. Watson

Since Specialization
Citations

This map shows the geographic impact of Douglas C. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas C. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas C. Watson more than expected).

Fields of papers citing papers by Douglas C. Watson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas C. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas C. Watson. The network helps show where Douglas C. Watson may publish in the future.

Co-authorship network of co-authors of Douglas C. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas C. Watson. A scholar is included among the top collaborators of Douglas C. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas C. Watson. Douglas C. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maayan‐Metzger, Ayala, et al.. (2024). Association of BNT162b2 SARSCoV‐2 vaccination during pregnancy with postnatal outcomes in premature infants. Acta Paediatrica. 113(10). 2275–2281.
2.
Watson, Douglas C., et al.. (2023). SARS-CoV-2 Infection of Young Infants during the Omicron Wave: A Case Series. SHILAP Revista de lepidopterología. 8(1). 10–14. 1 indexed citations
3.
Sadler, Marie C., et al.. (2020). Computational Surveillance of Microbial Water Quality With Online Flow Cytometry. Frontiers in Water. 2. 9 indexed citations
4.
Rainwater‐Lovett, Kaitlin, Carrie Ziemniak, Douglas C. Watson, et al.. (2017). Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection. PLoS ONE. 12(2). e0170548–e0170548. 20 indexed citations
6.
King, Jennifer R., Edward P. Acosta, Ram Yogev, et al.. (2009). STEADY-STATE PHARMACOKINETICS OF LOPINAVIR/RITONAVIR IN COMBINATION WITH EFAVIRENZ IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PEDIATRIC PATIENTS. The Pediatric Infectious Disease Journal. 28(2). 159–161. 6 indexed citations
7.
Persaud, Deborah, Stuart C. Ray, Aima A. Ahonkhai, et al.. (2007). Slow Human Immunodeficiency Virus Type 1 Evolution in Viral Reservoirs in Infants Treated with Effective Antiretroviral Therapy. AIDS Research and Human Retroviruses. 23(3). 381–390. 51 indexed citations
8.
Lambert, John S., Elizabeth S. Machado, Douglas C. Watson, et al.. (2007). Production of the HIV-Suppressive Chemokines CCL3/MIP-1α and CCL22/MDC Is Associated with More Effective Antiretroviral Therapy in HIV-Infected Children. The Pediatric Infectious Disease Journal. 26(10). 935–944. 10 indexed citations
9.
Watson, Douglas C. & Debra Counts. (2004). Growth hormone deficiency in HIV-infected children following successful treatment with highly active antiretroviral therapy. The Journal of Pediatrics. 145(4). 549–551. 6 indexed citations
10.
Machado, Elizabeth S., John S. Lambert, Douglas C. Watson, et al.. (2003). Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy. Journal of Clinical Virology. 30(1). 24–31. 26 indexed citations
11.
Watson, Douglas C., et al.. (1999). Antiretroviral Therapy of Pediatric HIV Infection: Making Hope a Reality. AIDS Patient Care and STDs. 13(10). 587–599. 1 indexed citations
12.
Watson, Douglas C. & John Farley. (1999). Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. The Pediatric Infectious Disease Journal. 18(8). 682–689. 159 indexed citations
13.
Watson, Douglas C., et al.. (1996). Suppression of the antibody response to a polymorphic peptide from the platelet alloantigen integrin β3 with low molecular weight antigen arrays. The Journal of Immunology. 156(7). 2443–2450. 5 indexed citations
14.
Symer, David E., et al.. (1996). Low molecular weight antigen arrays delete high affinity memory B cells without affecting specific T-cell help. Molecular Immunology. 33(17-18). 1377–1388. 13 indexed citations
15.
Schroeder, Jeffery A., et al.. (1995). Identification and Simulation Evaluation of a Combat Helicopter in Hover. Journal of Guidance Control and Dynamics. 18(1). 31–38. 12 indexed citations
16.
Schroeder, Jeffery A., et al.. (1991). Identification and simulation evaluation of an AH-64 helicopter hover math model. AIAA Atmospheric Flight Mechanics Conference. 6 indexed citations
17.
Robbins, John B., Chiayung Chu, Douglas C. Watson, et al.. (1991). O-Specific Side-Chain Toxin-Protein Conjugates as Parenteral Vaccines for the Prevention of Shigellosis and Related Diseases. Clinical Infectious Diseases. 13(Supplement_4). S362–S365. 16 indexed citations
18.
Chu, Chiayung, et al.. (1991). Preparation, Characterization, andImmunogenicity ofConjugates ComposedoftheO-Specific Polysaccharide ofShigella dysenteriae Type1(Shiga's Bacillus) BoundtoTetanus Toxoid. 1 indexed citations
19.
Watson, Douglas C. & Jeffery A. Schroeder. (1990). Effects of stick dynamics on helicopter flying qualities. 7 indexed citations
20.
Watson, Douglas C., et al.. (1985). Mental health and deafness : strategic perspectives. Medical Entomology and Zoology. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026